On December, 14th, we will discuss the organizing and conducting Phase I and Bioequivalence clinical

On December, 14th at 11:00 am, we will hold a webinar on the “Phase I and Bioequivalence clinical trials”.

Early phase studies is the most important stage of the drug development process. Firstly, volunteers and patients take medicine for the first time ever, so it can be dangerous. Secondly, the decision about the future of the drug can be made. So we make specific demands to the sites. It will be discussed on the webinar.

Register to webinar

What will we discuss in Webinar?

  • The specifics of Phase I and Bioequivalence clinical trials ;

  • The demands to the sites;

  • The specifics of quality assurance;

  • The specifics of clinical trials with healthy volunteers participation.

For whom?

For drug developers, pharmaceutical and biotech companies, participants in the clinical trial market, doctors.


Evgenia Ejova, IPHARMA Project Manager

Konstantin Semenov, IPHARMA QA Director

How to participate?

To participate in the webinar you should register.

On December, 12th you will receive an email invitation with a link to the broadcast.

Can I ask the questions?

You can ask preliminary questions which you would like to discuss in the registration application.

It is also possible to ask questions in Chat form during the broadcast on the YouTube channel, you will need to log in with your Google Account or create an account.

What if I miss the webinar?

All webinars are recorded and you can watch it on YouTube IPHARMA channel.

#webinar #PhaseI #bioequivalence

Недавние посты